[Prospects for using ladasten preparations in patients with irritable bowel syndrome].
Uspenskiĭ IuP, Fominykh IuA · 2010 · Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology; 2010
Study findings
The abstract describes Ladasten use in patients with irritable bowel syndrome and asthenic symptoms but provides no sample size, comparison details or numerical outcomes.
- Population and setting
- Patients; see abstract scope
- Evidence type
- Uncontrolled human report
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Original full text and detailed methods have not been reviewed.
- Sample size, allocation, masking and numerical outcomes require full-text appraisal; the report cannot establish effects in healthy users.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and English abstract checked.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: Uspenskiĭ IuP, Fominykh IuA. [Prospects for using ladasten preparations in patients with irritable bowel syndrome]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology; 2010 2010.
Molekul research summary: https://molekul.io/research/brom-extra-21434378. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry